As of 2024-12-15, the Fair Value of Prostatype Genomics AB (PROGEN.ST) is -39.36 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.90 SEK, the upside of Prostatype Genomics AB is -461.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -8.55 | -17.41 | -15.63 | -29.09 | -41.44 | -22.42 |
| YoY growth | 8.26% | -103.63% | 10.22% | -86.09% | -42.45% | -42.74% |
| Market Cap (mil) | 56.14 |
| P/E | |
| Forward P/E |
| EPS | -7.87 |
| Avg earnings growth rate | -42.74% |
| TTM earnings | -40.54 |